Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

Affiliations

¹ Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Medical Biology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
³ Department of Experimental Cardiology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
⁴ Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands.
⁵ Central Animal Facility, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁶ Groningen Small Animal Imaging Facility, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁷ Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁸ Netherlands Heart Institute, Utrecht, the Netherlands.
⁹ Department of Genetics, University of Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.
¹⁰ Department of Physiology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
¹¹ Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. r.a.de.boer@umcg.nl.

Published Erratum

Tim R Eijgenraam et al. Sci Rep. 2020.

. 2020 Oct 2;10(1):16710.

doi: 10.1038/s41598-020-70780-x.

¹ Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Medical Biology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
³ Department of Experimental Cardiology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
⁴ Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands.
⁵ Central Animal Facility, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁶ Groningen Small Animal Imaging Facility, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁷ Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁸ Netherlands Heart Institute, Utrecht, the Netherlands.
⁹ Department of Genetics, University of Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.
¹⁰ Department of Physiology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
¹¹ Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. r.a.de.boer@umcg.nl.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy.
Eijgenraam TR, Boukens BJ, Boogerd CJ, Schouten EM, van de Kolk CWA, Stege NM, Te Rijdt WP, Hoorntje ET, van der Zwaag PA, van Rooij E, van Tintelen JP, van den Berg MP, van der Meer P, van der Velden J, Silljé HHW, de Boer RA. Eijgenraam TR, et al. Sci Rep. 2020 Jun 17;10(1):9819. doi: 10.1038/s41598-020-66656-9. Sci Rep. 2020. PMID: 32555305 Free PMC article.